BLACKSBURG, VA,—January 14, 2019 – Landos Biopharma, Inc. Chairman and CEO, Dr. Josep Bassaganya-Riera, spoke with Emily Hayes of The Pink Sheet, an online pharma intelligence magazine, providing insight into the completion of Phase 1 testing for lead asset BT-11, outlook into Phase 2 clinical program in ulcerative colitis and Crohn’s disease, and future value catalysts for 2019 and 2020.